1.Zeisel, M et al. (2015) Host-targeting agents to prevent and cure hepatitis C virus infection. Viruses 7, 5659–5685.
2.Gokhale, NS et al. (2014) Hepatitis C virus: strategies to evade antiviral responses. Future Virology 9, 1061–1075.
3.Foster, GR et al. (2016) Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis. Journal of Hepatology 64, 1224–1231.
4.Goubau, D et al. (2014) Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates. Nature 514, 372–375.
5.Grebely, J et al. (2014) The effects of female sex, viral genotype, andIL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology 59, 109–120.
6.Prokunina-Olsson, L et al. (2013) A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus. Nature Genetics 45, 164–171.
7.Higgins, SC et al. (2010) TLR, NLR agonists, and other immune modulators as infectious disease vaccine adjuvants. Current Infectious Disease Reports 12, 4–12.
8.Kawai, T et al. (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. International Immunology 21, 317–337.
9.Gack, MU (2014) Mechanisms of RIG-I-like receptor activation and manipulation by viral pathogens. Journal of Virology 88, 5213–5216.
10.Li, K et al. (2017) Promising targets for cancer immunotherapy: TLRs, RLRs, and STING-mediated innate immune pathways. International Journal of Molecular Sciences 18, 404.
11.Uchikawa, E et al. (2016) Structural analysis of dsRNA binding to anti-viral pattern recognition receptors LGP2 and MDA5. Molecular Cell 62, 586–602.
12.Loo, Y et al. (2011) Immune signaling by RIG-I-like receptors. Immunity 34, 680–692.
13.Yoneyama, M et al. (2007) Function of RIG-I-like receptors in antiviral innate immunity. Journal of Biological Chemistry 282, 15315–15318.
14.Kawai, T et al. (2008) Toll-like receptor and RIG-1-like receptor signaling. Annals of the New York Academy of Sciences 1143, 1–20.
15.Thompson, AJV et al. (2007) Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunology and Cell Biology 85, 435–445.
16.Ou, STCA (2017) Hepatitis C virus-induced autophagy and host innate immune response. Viruses 9, 224.
17.Shi, J et al. (2017) Current progress in host innate and adaptive immunity against hepatitis C virus infection. Hepatology International 11, 374–383.
18.Youssef, SS et al. (2017) SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4. Archives of Virology 162, 1–8.
19.Liu, F et al. (2011) Retinoic acid inducible gene-I, more than a virus sensor. Protein & Cell 2, 351–357.
20.Haralambieva, IH et al. (2011) Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine. Vaccine 29, 8988–8997.
21.Kennedy, RB et al. (2012) Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes. Vaccine 30, 2159–2167.
22.Biggins, SW et al. (2013) Differential effects of donor and recipient IL28B and DDX58 SNPs on severity of HCV after liver transplantation. Journal of Hepatology 58, 969–976.
23.Ovsyannikova, IG et al. (2010) Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Human Genetics 127, 207–221.
24.Chen, Y et al. (2017) Hepatitis C virus genotypes and subtypes circulating in Mainland China. Emerging Microbes & Infections 6(11), e95.